Signal Detection throughout the Product Life Cycle

Pharmaceutical Education Associates Presents:

Signal Detection throughout the Product Life Cycle

– The Park Hyatt at the –

Pharmaceutical companies have been tracking adverse events, drug reactions and drug safety issues for years.  Now, the most successful companies are implementing innovative methods and ways of data mining into complex, multi-faceted databases to proactively identify and analyze signals that occur not only in post-marketing surveillance, but in all phases of drug development as well. 

Even the regulatory agencies like the FDA are developing new recommendations for analyzing data that will help in identifying signals earlier – even in early clinical development.  Pharmaceutical companies must keep in pace with these new developments or risk being identified by the regulators as non-compliant and not up to current standards.